Lineage Cell Therapeutics (LCTX) Other Non Operating Income (2010 - 2026)
Lineage Cell Therapeutics (LCTX) reported Other Non Operating Income of $1000.0 for Q1 2026, up 100.43% on a YoY basis from $498.92 in Q1 2025, and down 99.79% quarter-over-quarter from $482000.0 in Q4 2025.
Lineage Cell Therapeutics (LCTX) Other Non Operating Income (2010 - 2026) Analysis & Trends
Lineage Cell Therapeutics has reported Other Non Operating Income for 17 years, with the latest figure at $1000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Non Operating Income rose 100.43% year-over-year to $1000.0; the trailing twelve-month figure through Mar 2026 stood at $509000.0 (up 185.12% YoY), and the FY2025 full-year result was $2.1 million, up 420.6% from the prior year.
- Other Non Operating Income for Q1 2026 stood at $1000.0, down from $482000.0 in the prior quarter.
- The five-year high for Other Non Operating Income was $482000.0 in Q4 2025, with the low at -$1.1 million in Q4 2023.
- Historically, Other Non Operating Income has averaged -$153857.1 across 5 years, with a median of $1000.0 in 2023.
- Annual changes were most pronounced in 2023 — Other Non Operating Income sank 373.37% — and 2025, when it jumped 224.87%.
- Lineage Cell Therapeutics' Other Non Operating Income stood at $398000.0 in 2022, then slumped by 373.37% to -$1.1 million in 2023, then soared by 64.52% to -$386000.0 in 2024, then jumped by 224.87% to $482000.0 in 2025, then tumbled by 99.79% to $1000.0 in 2026.
- The last three Other Non Operating Income figures came in at $1000.0 (Q1 2026), $482000.0 (Q4 2025), and $26000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Lineage Cell Therapeutics | 303.84 Mn | 239.94 Mn | 1.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,000.00 |
| Dec 31, 2025 | 482,000.00 |
| Jun 30, 2025 | 26,000.00 |
| Mar 31, 2025 | -231,000.00 |
| Dec 31, 2024 | -386,000.00 |
| Jun 30, 2024 | 19,000.00 |
| Dec 31, 2023 | -1.09 Mn |
| Sep 30, 2023 | 1,000.00 |
| Jun 30, 2023 | 86,000.00 |
| Mar 31, 2023 | 457,000.00 |
| Dec 31, 2022 | 398,000.00 |
| Sep 30, 2022 | -475,000.00 |
| Jun 30, 2022 | -709,000.00 |
| Mar 31, 2022 | -735,000.00 |
| Dec 31, 2021 | 1.80 Mn |
| Sep 30, 2021 | 393,000.00 |
| Jun 30, 2021 | 590,000.00 |
| Mar 31, 2021 | -1.68 Mn |
| Dec 31, 2020 | 2.71 Mn |
| Sep 30, 2020 | 351,000.00 |